Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-04-19
1996-02-13
Chan, Christina Y.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530317, 530323, C07K 754, A61K 3812, A61K 3815
Patent
active
054911281
ABSTRACT:
The invention concerns the aglycons of factors A1, A2, A3, A'1, A'2, A'3 of antibiotic A/16686, their corresponding tetrahydroderivatives and mixtures thereof. The aglycons are produced by the selective hydrolysis of antibiotic A/16686 factor A1, A2, A3, A'1, A'2 or A'3. The compounds have antibacterial activity against widely diffused gram positive bacteria and are particularly useful for topical treatment of wound infections and acne.
REFERENCES:
patent: 4303646 (1981-12-01), Cavalleri et al.
patent: 4427656 (1984-01-01), Cavalleri et al.
patent: 4661470 (1987-04-01), Malabarba et al.
patent: 5108988 (1992-04-01), Ciabatti et al.
Morita et al., J.C.S. Chem. Comm. pp. 874-875 (1978).
Cavalleri et al., The Journal of Antibiotics, vol. XXXVII, No. 4, pp. 309-317 (Apr. 1984).
Cavalleri et al., The Journal of Antibiotics, vol. XL, No. 1, pp. 49-59 (Jan. 1987).
Cavalleri Bruno
Ciabatti Romeo
Chan Christina Y.
Dixon J. Michael
Gruppo Lepetit S.p.A.
LandOfFree
Aglycons of A/16686 antibiotics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aglycons of A/16686 antibiotics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aglycons of A/16686 antibiotics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-240593